Okklo Life Sciences Information

View Top Employees from Okklo Life Sciences

Okklo life sciences BV is a privately held biopharmaceutical company developing novel therapeutic solutions using cyclodextrin-based technologies. The current programs are focussed on lysosomal storage disorders and cardiovascular disorders. The company was founded in December 2011 by a group of life-sciences experts previously involved in the development and approval of sugammadex (Bridion™), the first modified cyclodextrin marketed as a drug product. We are continuously looking for collaborations and partnering opportunities with public and private partners - please visit our website to learn more about our technology platform strategy and development pipeline.

Website	http://www.okklo.com
Revenue	$5 million
Employees	3 (0 on RocketReach)
Founded	2011
Address	5 Transistorweg, Nijmegen, Gelderland, NL
Phone	+31 6 10489150
Technologies	JavaScript , HTML , PHP +5 more (view full list)
Industry	Pharmaceutical Manufacturing, Business Services General, Business Services
Keywords	Biopharmaceutical, Lysosomal Storage Disorders, Rare Diseases, Therapeutic Solutions, Novel Therapeutics, Drug Development, Biotechnology, Drug Discovery, Drug Delivery, Pharmaceutical Research, Life Sciences Research, Therapeutics, Biotechnology Research, Clinical Trials, Pharmaceutical, Medical Research, Clinical Development, Health Technology
Competitors	Novartis, AstraZeneca, Genentech, Amgen, Regeneron, Gilead Sciences, Vertex Pharmaceuticals, Illumina, Biogen, Sangamo Therapeutics, Inc. +41 more (view full list)
SIC	SIC Code 873 Companies, SIC Code 87 Companies
NAICS	NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies